1.Introduction
According to the World Health Organization (WHO), cancer is the leading cause of death all around the world. 1 One of the defining features of cancer is the rapid creation of abnormal cells that grow beyond their usual boundaries, which can then invade adjoining parts of the body and spread to other organs, the latter process is known as metathesis. Photodynamic therapy (PDT) is non-invasive and one of the most extensively used techniques for dermatological diseases and various types of cancers, which could be used to control and selectively treat solid tumors. [2] [3] [4] The main advantage of PDT over traditional therapies such as surgery, radiation and chemotherapy are that PDT produces fewer side effects. PDT requires a photosensitizer or photosensitizing agent (PS) that is therapeutically activated in the presence of light. 5 Ideally, the PDT reagent should not show any such activity in the dark. The activity of such PDT reagents mainly depends on the efficiency of the PS molecule or fragment in generating long-lived excited state. On excitation of the PS moiety at an appropriate wavelength, energy or electron transfer process eventually lead to the generation of reactive oxygen species (ROS) like superoxide anion (O 2 •ˉ) , hydroxyl radical (HO •ˉ) , hydrogen peroxide and singlet oxygen ( 1 O 2 ). Such ROS species are known to be cytotoxic to living cells and can be judiciously utilized for targeted singlet oxygen chemotherapy. Tumor metastasis is a multistep biological process that allows cancer cells to move away from the primary tumor, survive in the circulation system, locate in distal sites and grow. 6 Thus, more recently it has been argued that effective treatment for cancer largely depends on therapeutics that not only induces cell cycle arrest but also possess anti-metastatic activity. Commercially available PS agents such as hematoporphyrins and its derivatives (HpD) generally suffer from drawbacks such as low solubility in aqueous solutions and weak absorption band at 630 nm. This necessitates the use of high light doses of 100-200 J/cm 2 to achieve the desired control of tumor growth.
Also, common PDT drugs like Porfimer sodium can cause severe side effects, as they are retained in the body for about 4 months and results in skin photosensitivity. 7 More recently, the European Union has approved the use of meso-tetra hydroxyphenyl chlorin (mTHPC) as a PS for PDT application. [5] [6] [7] However, these agents suffer from poor stability in physiological conditions and also photobleach on photoirradiation. 5, 8 These drawbacks limit the use of these reagents for PDT applications; thus, there is a definite scope for developing appropriate reagents that can overcome foresaid disadvantages. After the successful entry of ruthenium-based drugs (NAMI-A and KP1019) into human clinical trials, there is a burgeoning interest in developing Ru(II)-based novel anticancer drugs with new and improved function. 8, 9 The possibility of achieving high solubility by choosing appropriate counter anions or through appropriate functionalization of the coordinated ligands has led to the design of new Ru(II)polypyridyl complexes for use of anti-cancer and antimetastatic drugs. 10, 11 These complexes are attractive choices for use as photodynamic therapeutic reagents and they also possesses visible light excitation, reasonably long-lived triplet excited states, and higher stability towards photobleaching. 7 Recent reports suggested that the conjugation of biologically relevant molecules to the Ru(II)-polypyridyl complexes can improve cellular internalization. 12, 13 Ru(II)-polypyridyl complexes with appropriately functionalized bpy derivative can enhance lipophilicity and can lead to more efficient internalization. [14] [15] [16] [17] Herein, we investigated the use of two Ru(II)-polypyridyl based reagents with pendant tyrosine or tryptophan moiety as efficient PDT reagents. Photo-induced cytotoxicity, anti-metastatic property, cellular uptake and ROSmediated DNA cleaving pathways for these two complexes (1 and 2) are described. Significantly it has been found that these systems are active as PDT sensitizers at light doses as low as 10 J/cm 2 .
Results and discussion
Synthesis of 1 and 2 was achieved by following previously reported literature procedures. 18, 19 Both complexes were characterized using a range of spectroscopic and analytical techniques. All these spectroscopic data, as well as the results of elemental analysis, confirm the desired purity for both complexes utilized in our studies ( fig. S8-11 ). The photophysical properties of these two complexes are well established and this is the primary reason for choosing them for our studies. Tyrosine is a non-essential amino acid that plays a crucial role in the protein synthesis and acts as a receiver of phosphate groups in biological systems that are transferred by way of protein kinases (so-called receptor tyrosine kinases). 20 Also, it is involved in the mechanism of photosynthetic oxidation of water into molecular oxygen in photosystem II (PSII). 21 The tryptophan moiety that is utilized in designing complex 2 is an essential amino acid that cannot be synthesized by higher organisms. Tyrosine and tryptophan derivatives are known to readily cross the blood-brain barrier and facilitate cellular internalization. 22 On the other hand, Ru(II)-polypyridyl complexes are known to generate reactive oxygen species (ROS) up on irradiation into their MLCT band in the visible region of the spectrum. [23] [24] [25] [26] As outlined above, such ROS species damage biomolecules and are therefore cytotoxic to living cells. [27] [28] [29] Since these two complexes are functionalized with amino acid moieties to enhance cellular internalization and possess well-defined photophysical/physicochemical properties, their capability to photo-induced damage to the DNA and function as cytotoxic agents was investigated. 
DNA binding studies.
Water soluble complexes 1 and 2 with Clˉ as counter anion were obtained via anion metathesis. The interactions of complexes 1 and 2 with CT-DNA were investigated using UV-Visible and fluorescence spectroscopy. The addition of small aliquots of CT-DNA to the buffer solution containing 1 or 2 led to an appreciable hypochromic shift in the π→π* (290 nm) based transition, while slight change was registered for the MLCT (450 nm)-based absorption band ( Fig. S1 ) for the respective complex. Such changes are not uncommon for reagents that are not bound to DNA structure though intercalative mode of binding. 30, 31 Luminescence studies revealed that addition of CT-DNA to the aq. buffer solutions of 1 and 2 led to the enhancement in the fluorescence intensity of the respective complexes. The binding affinity K a , and site size S for the respective complexes were calculated by fitting the obtained data from UV-Visible and fluorescence spectroscopic titrations into McGhee Von-Hippel model (table  1) . The binding parameters evaluated using these two different optical titration methods were found to be in good agreement. The relatively high affinities observed suggest that the interaction of these systems with DNA is not solely due to electrostatics. Isothermal titration calorimetry studies with CT-DNA.
Binding constants and other thermodynamic parameters for the interaction of complexes 1 and 2 with CT-DNA were also evaluated using isothermal titration calorimetry (ITC) measurements. Relevant thermographs are displayed in figures 2a and 2b. The binding affinity of 1 (K a 1 = 1.18 X 10 5 M -1 ) and 2 (K a 2 = 1.57 X 10 5 M -1 ) towards CT-DNA were in good agreement with those obtained from VU-Visible and luminescence titrations. Since, ITC and spectroscopic techniques used two different binding models to calculate the binding constant (K a ) and site size (N), it is not unreasonable to see a minor difference in the values evaluated for K a and N (bp) following two different techniques. Data are shown in table 2 clearly reveal that the binding process was entropically driven with the best fit for the integrated heat data being obtained using a single set of identical sites model. This thermodynamic profile is indicative of non-covalent interactions between DNA and the complexes and is consistent with hydrogen bonding. Since both complexes contain amino acid moieties with a set of donor and acceptor sites these observations are not unexpected: we have previously demonstrated that somewhat related systems possessing hydrogen bonding sites can bind DNA with high affinities. 32 All these observations suggested that 1 and 2 interact with CT-DNA predominantly through groove binding and certainly not through intercalation. To corroborate this result, we performed the viscosity measurements with CT-DNA which also confirmed the groove binding of complex 1 and 2 (Fig. S2 ). This is consistent with the observed evidence of hydrogenbonding, as this interaction would require the amino-acid based ligand to sit in a DNA groove so that it can make close contact with base pairs.
Plasmid DNA photo-cleavage: Gel electrophoresis studies.
We also investigated possible mechanisms of cell death caused by complexes 1 and 2. To assess the DNA-damaging ability of 1 and 2 upon photo-irradiation, we conducted the gel electrophoresis experiment with pUC19 plasmid DNA after incubation with 1 or 2. Agarose gel images of pUC19 plasmid DNA ( Fig. 3 ) clearly revealed that the photo-irradiated of plasmid DNA samples incubated with 1 and 2 leads to conversion of supercoiled DNA (SC) into nicked circular form(NC). No such DNA cleavage has been found when the dark incubated samples ran on the agarose gel. It is well documented in the literature that Ru(II)-polypyridyl complexes can convert water or molecular oxygen into the respective ROS species (OH • or 1 O 2 ) following an energy transfer process involving their 3 MLCT state. 5, [28] [29] [30] [31] To understand the role of ROS which could be responsible for the observed pUC19 plasmid DNA cleavage, the control experiments were performed by incubating the plasmid DNA 1 ( confirm that these two complexes fail to generate any DNA damage in the dark. To prove the in-situ generation of 1 O 2 on photo-irradiation of 1 and 2, we have recorded its phosphorescence band for 1 O 2 that appears in the NIR region at 1275 nm ( Fig. S3 ).
Evaluation of 1 O 2 production ability by 1 and 2.
For PDT application, relatively high quantum yield of 1 O 2 (~0.5) is desired. 10 We Please do not adjust margins Please do not adjust margins of singlet oxygen quantum yield. 36 The nature of the solvent had pronounced influence on the efficiency photosensitization and generation of 1 O 2 . 
Light-induced cytotoxicity: MTT assay
Since photoexcited Ru(II)-polypyridyl complexes are known to generate ROS, we then examined the light-induced cytotoxicity of complexes 1 and 2 towards the two different cancer cell lines. Live human lung cancer (A549) and colon cancer (Hct116) cells were incubated with 1 and 2 for 4 h in the dark and photo-irradiation conditions. The cells were photoirradiation at the MLCT wavelength of 1 and 2 with visible light source (λ Range ~ 450 -480 nm having the flux of 10 J/cm 2 ) under otherwise identical conditions. MTT assay studies revealed ( Fig. 4 ) that these two complexes are non-toxic in dark conditions (IC 50 > 300 µM) with more than 85 % of the cells surviving even at 300 µM concentration. However, upon photo-irradiation, the calculated IC 50 values were 25 and 28 µM respectively for complexes 1 and 2 (table. S1). A substantial difference in light and dark IC 50 values suggested that these complexes could have possible application as PDT agent.
It is worth mentioning that literature reports suggest most initial drug screening is performed with two-dimensional cell culture. 9,37-39 A solid cancer, such as those of the breast, colon, stomach, lung and liver, is a tumor mass that is hypoxic at the center and denser than the surrounding tissue. In this context, 3D cell culture model has been developed, where 3D cell culture model performs better than the commonly used 2D models in capturing the complexity of in-vivo processes within the tumor microenvironment and provide a more realistic physiological environment than traditional monolayer cultures. 37, 40 3D tumor spheroids mimic the pathophysiology of tumors, including hypoxic/necrotic regions as well as mimicking the changes in cell shape, the high proportions of quiescent cells, alterations in gene expression profiles, and diminished permeability to drugs. 41 Spheroids exhibit the phenomena of multicellular resistance (MCR), which is manifested in the diminished efficacy of chemotherapeutics similar to in-vivo activities. 42 Thus, to examine the cytotoxicity of these two photo-responsive Ru(II)-polypyridyl complexes towards such 3D tumors under more biologically relevant conditions, treatment efficacy was examined with 3D tumor model by generating tumor spheroids with A549 and Hct116 cells. Spheroids of ca. 600 μm in diameter were dosed with compounds 1 and 2 (10 -300 µM) and then these tumors were either kept in the dark for control experiments or were kept under photo-irradiation ( Fig. S5 ). Significant photo-induced cytotoxicity was observed for both complexes (1 and 2) with an IC 50 values two different cell lines are provided in the table S2. For control experiments, where cells were kept in the dark conditions, more that 95 % of the cell survival was observed for [1] or [2] of ~ 300 μM. These data clearly revealed that both complexes are non-toxic to live A549 and Hct116 cells when incubated in dark and showed significant light-induced cytotoxicity towards these cells. Further, our studies revealed that, in 3D tumor models a 2-fold increase in IC 50 values as compared to the 2D cell models. One of the required properties for an ideal photosensitizer is that the PS should have a higher phototoxic index (PI = IC 50 in the dark/IC 50 upon irradiation) 28 and must be activated at a specific wavelength, preferably in the visible or near-IR region due to the deeper penetration of light into tissue. In this present study, we have also calculated the PI for our photo-active molecules with excitation wavelength at λ = 450 nm. From the table S2, the calculated PI values for the complex 1 and 2 towards A549 cancer cell lines are >10 % and > 4 % in 2D and 3D cell cultures respectively. We also had performed MTT assay studies to find out the specific ROS that could be accounted for the cell death. Please do not adjust margins
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To investigate the possibility of DNA damage at cellular level, single-cell gel electrophoresis (SCGE) or comet assay was performed. 43 The comet assay is based on the lyses of cells with non-ionic detergent like Triton-X and high-molarity sodium chloride. This treatment removes/dissolves cell membranes, cytoplasm, and nucleoplasm as well as disrupts nucleosomes, as most of the histone is solubilized by alkali solution. 44 We treated A549 cells with 1 (30 µM) and 2 (30 µM)
following photo-irradiation. For control experiments, an identical reaction mixture was kept in the dark conditions. From Fig 5a, the electrophoresis of the comet slide containing cells treated with 1 in presence of light reveals cleavage of DNA (Fig. 5a , i-iv); but no cleavage was observed in the case of cells treated with 1 in dark conditions (Fig. 5a , v-viii).
Comparable results were observed for complex 2 (Fig. 5b i-iv, Photo-irradiated cells and Fig. 5a v-viii, cells in the dark). Images from fluorescence microscopy revealed the expected comet-like structures and the intensity of the comet tail relative to the head reflected the number of DNA breaks. SYBR green was used to visualize DNA on exposure to UV light. Increases in the longer and darker comet tail directly reflect the extent of DNA damage. The fluorescence intensity profile plots for 1 ( Fig. 5a iii, viii) and 2 ( Fig. 5b iii, viii) indicate that DNA damage in the tail is higher than the heads of the comets. The percentage of DNA damage was quantified by using ImageJ software ( fig. S7 ). From this data, we conclude that the complex 2 caused more damage to the DNA in A549 cells than the complex 1. One could find the photo-irradiated samples cleaved cellular DNA more efficiently compared with the dark incubated samples. 
Cellular uptake and CLSM imaging studies.
Since complexes 1 and 2 showed significant photo-induced cytotoxicity towards A549 cancer cell lines, we have further conducted confocal laser scanning microscopy (CLSM) studies to identify the cellular accumulation of these photo-toxic complexes. The cell imaging studies were performed by incubating 1 (Fig. 6a ) and 2 (Fig. 6b ) with live A549 cells. Colocalization studies were then performed using commercially available mitotracker green. Figure 6a , b shows that neither of the complexes entered the cell nucleus. A close comparison of the merge image with mitotracker green clearly revealed the intracellular emission of 1 and 2 from the cytoplasm. From the merge images one can see that both the complexes were targeting the mitochondria. Also, a distinct emission was observed from the cell membrane, indicating that the cell membrane is also a target for these reagents. Literature reports have demonstrated that more lipophilic cationic reagents generally accumulate preferentially in the cell membrane while analogous reagents with comparable overall charge but relatively lower lipophilicity preference the nucleus. 45, 46 The dot-like structures with red fluorescence observed from the cytoplasm and cell membrane are reminiscent of another lipophilic Ru(II)-polypyridyl complexes which is observed in phospholipid bilayer of the cell membrane. 47 Figure 6 . CLSM images of A549 cells incubated with 1(a) and 2 (b). Co-localization studies performed with mitotracker green.
Such dot like structures, scattered in the cytoplasm, are attributed to localization of these reagents in cytoplasmic vacuoles, which are known to play a subordinate role in endocytosis. 48, 49 Partition coefficient logP measurement.
The partition coefficient (logP) values were calculated using the shake-flask method to determine the lipophilicity of 1 and 2. Results shown in table 3 clearly reveal that the lipophilicity of complex 1 (logP = -1.31) is higher than 2 (logP = -1.72). The logP for the model Ru(II)-polypyridyl complex ([Ru(bpy) 2 (dmbpy)] 2+ ; logP = -1.01) was also evaluated. These values suggest that the conjugation of the amino acids i.e., tyrosine and the tryptophan to the Ru(II)-polypyridyl moiety have certainly influenced the logP values of the final complexes 1 and 2. It has been previously argued that the lipophilicity of a complex is more important than its overall charge in influencing cellular internalization. [50] [51] [52] The lipophilicity for the complexes used in this study follows the order [Ru(bpy) 2 (dmbpy)] 2+ > 1 > 2 (table 5) . The trend in cellular internalization expected by these data was confirmed by MP-AES (Microwave Plasma Atomic Emission Spectroscopy) studies (ESI, table S2) as cellular uptake follows the same order i.e., [Ru(bpy) 2 (dmbpy)] 2+ > 1 > 2.
Wound Healing assay
As it was discussed above the metastasis of tumors is a multistep biological process that allows cancer cells to get away from the primary tumor, survive and grow in some other parts of the human body. 11, 10, 53, 54 Many researchers have suggested that effective therapy for cancer or efficient ways of treating a cancer patient essentially depends on the antimetastatic activity of the chemotherapeutic PS drugs. 3,10 from the MTT assay, it is evident that these two complexes have good potential for interrupting cancer cell proliferation in the presence of visible light. To further check this possibility, we performed wound healing assay experiments with highly metastatic MDA-MB231 cells. Complexes 1 and 2 were incubated with MDA-MB231 cells in the presence of visible light, while analogous model experiments were performed in the dark conditions. A wound was created using wound creating stick just prior to the addition of the complexes 1 or 2.
Then these MDA-MB231 cells were incubated with 1 or 2 for 4 h on photo-irradiation and then cells were kept in the dark for 10 h. For control experiments, MDA-MB231 cells were incubated with 1 or 2 for 14 h in dark. Bright-field images were captured at different time intervals. However, images recorded at 0 min and after 10 h are shown in fig. 7 . fig. 7d (for complex 1) and fig. 7h (for complex 2) clearly reveal that cells that were initially irradiated for 4 h with visible light in the presence of 1 or 2, failed to migrate and to heal the wound. However, figs. 7b (for complex 1) and 7f (for complex 2) reveal that MDA-MB231 cells that were kept in dark with complexes 1 or 2 could migrate to the other end and the respective wound was almost healed. The distance travelled by the cells were calculated and plotted as a function of the concentration of reagent 1 (fig. 7i) or 2 (fig. 7j ). These results indicate that the two Ru(II)-polypyridyl complexes do inhibit cell migration suggesting they may possess anti-metastatic activity.
Invasion assay.
As was discussed above one of the hallmarks of cancers is cell invasions and metastasis into nearby and distal organs initiated by various protein de-regulations of PTEN, MMPs, EGFR, and CD44. Highly metastatic cells lose cell to cell adherence and break off. These invade basement membrane and endothelial walls for entering the blood stream or lymph nodes. These cells are then carried away to distal organs are deposited and result in primary metastasis.
Here, the cells again invade endothelial walls and basement membrane, gets deposited, undergo cell division, and grow to form tumors. The tumor-forming cells still possess the characteristics to invade and settle into other organs for tumor formation. This eventually results in a secondary metastasis. Therefore, invasion and metastasis are two important aspects that need to be controlled to prevent spreading of cancer throughout the human body. To assess the potential of 1 and 2 Relative to 100 % cells invasion for a control experiment, the percentage of cells that invaded through matrigel was significantly reduced when experiments were performed with 1 (17.5 %) and 2 (37.5 %) under light irradiation conditions ( fig.  8 ). This experiment also revealed that the complex 1 prevents cell invasion more efficiently than complex 2.
Complex 1 and 2 induces apoptosis by caspase-3 activation.
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We next set out to elucidate the molecular mechanism responsible for light induced cell death by complexes 1 or 2. We examined if light induced cell cycle arrest occurred through the activation of DNA damage signalling pathways. For this, A549 cells were treated with complex 1 or 2 in the dark or under light irradiation. It was found that there was a significant increase in the expression level of apoptosis marker caspase-3 in photo-irradiated cells ( fig. 9 ). Figure 9 . A549 cells growing in serum-containing medium were treated with 1 and 2 for 24 h prior to lysate preparation and immunoblotting with antibodies. The blot was probed with primary antibodies against caspase-3. β -Actin levels were used as a loading control. All results are representative of two independent experiments.
Whereas in the dark treated samples there was no difference in the expression level of caspase-3. This indicates that on irradiation complex 1 and 2 induce apoptosis in the A549 cells.
As discussed earlier, exposure to visible light for cells incubated with 1 or 2 resulted in the generation of ROS ( 1 O 2 ). Singlet oxygen is known to damage the DNA and is also responsible for altering the mitochondrial trans membrane potential. Literature reports reveal that the pro-apoptotic proteins, released from mitochondria, are responsible for activation of caspase-3 and the cell finally leads to apoptosis. Thus, these photoactive compounds could be used for the treatment of solid tumors by specifically illuminating in the visible light which would not cause any ROS production in the dark condition.
Experimental

Materials and methods.
All chemicals were purchased from Sigma-Aldrich unless otherwise indicated. 1 HNMR spectra were recorded on a Bruker FT-NMR spectrometer at room temperature. ESI-MS measurements were carried out on a Waters QTof-Micro instrument. UV-Vis spectra were obtained by using a Cary 500 scan UV-Vis spectrometer. Complexes 1 and 2 were converted into their water-soluble chloride salts via anion metathesis. The CT-DNA concentration per nucleotide was determined by absorption spectroscopy by using the molar absorption coefficient (6600 mol -1 dm 3 cm -1 ) at 260 nm. The emission spectra were obtained using Edinburgh instrument Xe-900 spectrofluoremeter. Confocal microscopy images acquired using Olympus Fluoview microscope. Partition coefficient (logP) measurements were calculated using the shake-flask (noctanol/water) method. The absorbance of the respective complex in each phase was determined using UV-Vis spectroscopy. ITC experiments were performed with the Microcal iTC200. CT-DNA concentration (0.1 mmol) and complexes 1 (5 mmol), 2 (5 mmol) concentrations were used for these experiments. All titrations were conducted in Tris-HCl buffer (5 mmol Tris and 25 mmol NaCl), pH = 7.4 at 25° C. The resulting isotherms were fitted with the one set of site binding model provided with Microcal iTC200. A549 and Hct116 cells were cultured in DMEM respectively supplemented with 10% FBS and penicillin/streptomycin. Cell lines were maintained at 37 °C in an atmosphere of 5 % CO 2 and routinely sub-cultured. Cytotoxicity tests were performed using MTT assay in triplicate. Synthesis of Complexes 1 and 2: Complexes 1 and 2 were synthesized following previously reported literature procedures. The chloride salts of 1 and 2 were obtained by anion metathesis of their respective PF 6ˉ salts using [nBu 4 N]Cl in acetone for improved water-solubility. Characterization data for respective complex are given below. 
DNA binding titrations.
For absorption titrations, complexes 1 and 2 were converted to their chloride salts by treatment with [nBu 4 N]Cl in acetone. Complex solution (10 mL of a 10 mmol stock) in Tris-HCl buffer was then diluted into Tris buffer to give a final concentration of about 5 mm Tris buffer. This was loaded into another identical cuvette and placed in the reference cell of the spectrometer. After 30 min cell equilibration, the first spectrum was recorded between 600-200 nm. DNA solution (2-5 mL) was then added to both the sample and reference cell and mixed. The spectrum was taken again, this time showing the hypochromic shift indicating the formation of a drug-DNA complex. The titration process was repeated until there was no change in the spectrum for at least four titrations, indicating binding saturation had been achieved. Both buffer and complex solutions showed insignificant emission, so no reference cell was used. Buffer (3 mL) was loaded in a 1 cm path-length luminescence cuvette; an aliquot of buffer was removed and replaced with the same volume of a stock solution of complex (final concentration 5 mm). The cuvette was loaded into the spectrophotometer and incubated at 25° C. After equilibration, the emission spectrum of the solution was recorded by using the excitation wavelength characteristic of the complex. A concentrated stock of CT-DNA solution (2 mL) was added to the cuvette and mixed, and then the emission spectrum was recorded, which showed an enhancement in emission. This procedure was continued until the emission became constant. Emission titrations were successfully fitted to the McGhee-von Hippel model for binding to an isotropic lattice.
Isothermal Titration Calorimetry (ITC) studies.
ITC experiments were performed with the Microcal iTC200. CT-DNA concentration (0.1 mmol) and complexes 1 (5 mmol), and 2 (5 mmol) concentrations were used for these experiments. All titrations were conducted in Tris-HCl buffer (5 mmol Tris and 25 mmol NaCl), pH = 7.4 at 25 °C. In each titration, CT-DNA was loaded into the cell and complexes 1 or 2 were taken into the syringe. Aliquot of 2 µL of complexes were added to the cell containing DNA. In each experiment, the raw isotherms were corrected for the heat of dilution by subtracting the isotherms representing the complexes injected into the Tris-HCl buffer. The resulting isotherms were fitted with the one set of site binding model provided with Microcal iTC200. Singlet oxygen measurement studies.
N,N-Dimethyl-4-nitrosoaniline/histidine assay.
The singlet oxygen production was measured by the N,Ndimethyl-4-nitroso-aniline/histidine assay based on the oxidation of histidine by singlet oxygen and the subsequent reaction of the oxidised histidine with N,N-dimethyl-4nitrosoaniline as previously described. 45, 68 The absorbance of the compound was adjusted to approximately 0.2 at the irradiation wavelength. In practice, 20 mM DMSO stock solution of the compound to measure were diluted in 4 mL PBS solution (pH 7.4) containing N,N-dimethyl-4-nitrosoaniline (25 μM) and histidine (0.01 M) and irradiated in fluorescence quartz cuvettes (width 1 cm). Bleaching of N,N-dimethyl-4nitrosoaniline was followed by monitoring of the absorption at 440 nm. Negative control experiments were run by repeating the measurements in the absence of histidine. The same conditions were also used for singlet oxygen detection in acetonitrile, except that imidazole was used instead of histidine due to the low solubility of histidine in this solvent. In addition, the absorbance peak of N,N-dimethyl-4nitrosoaniline shifts to 415 nm in acetonitrile. The absorbance at 440/415 nm was then plotted as a function of irradiation time and the quantum yields of singlet oxygen formation (Φ sample ) were calculated using phenalenone as the standard (Φ reference ) with the following formula:
MTT assay and CLSM studies.
Cell cultures were treated with 0-300 µM solutions of 1 and 2 in triplicate for 24 h. After incubation 5 µL of MTT reagent was added and incubated for 4 h. MTT = (3-(4, 5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) dissolved in serum-free media. The media was removed and the formazan dissolved using isopropanol and the absorbance at 570 nm quantified by the plate reader (reference 620 nm). IC 50 values for the two complexes were found to be >300 µM. A549 cells were cultured in DMEM media. Cell lines were maintained at 37° C in an atmosphere of 5 % CO 2 and routinely sub-cultured. For CLSM, cell cultures were grown on 6 well plate with coverslips, after 24 h of incubation the cells were treated with solutions of 1 and 2 (30 µM,) in serum containing media and incubated for 4 h. After incubation media was removed and cells were washed with 1XPBS buffer. Co-localization staining studies were performed using mitotracker green form life technologies. Cells were fluorescently imaged on a Fluoview confocal laser scanning microscope by using 60X oil-immersion lenses. Complexes 1 and 2 were excited with a laser at 442 nm and emission monitored at 620 nm (red) wavelengths. Mitotracker was excited at 490 nm.
Wound healing (scratch motility) assay.
MDA-MB-231 cells were cultured in Leibowitz's L15 medium with 10 % FBs. 1 X 10 5 /mL cells were seeded in 6 well plate and incubated for 24 h at 37 °C, 5 % CO 2 incubator to form a monolayer. After 24 h gaps were created using pipette tip on the confluent monolayer and washed with media to remove cellular debris. The fresh medium supplemented with 10 % FBS was added into well and incubated with 1 and 2 (30 µM) for 4 h to allow the uptake by cells. Following with same conditions one cell culture plate was photo-irradiated for 4 h and the other place kept in the dark conditions. The cell migration observed and imaged at regular intervals (0-10 h) using Nikon live cell imaging microscope for 10 h. The rate of migration of the cells was calculated using image pro 6.0 software provided along with Nikon microscope. Comet assay.
Live A549 cells were incubated with 1 and 2 for 4 h and suspended the cells into PBS buffer. This suspension of the cells was embedded into the low melting agarose (0.5 %) gel. 100 µL of this mixture is poured on top of the agarose precoated comet slides. The coverslip was placed on top of the comet slides and removed after solidification of agarose. A549 cells were lysed with an alkaline solution over night at 4° C. Then slides were removed and rinsed twice with the rinsing solution to remove the residual amounts of excess salt and detergents. The comet slide incubated for 2 h in electrophoresis unit in 1X PBS buffer solution. Voltage (0.6 V/cm for 25 min with current of 40 mA) applied to accumulate the damaged DNA at the end of the cathode. Then slide was removed from electrophoresis chamber and rinsed with 400 mL of distilled water. Then the comet slide was placed in staining solution (syber green solution) for 20 min. Again, the comet slide was rinsed with 400 mL of deionized water to remove the excess stain. The DNA damage was visualized using microscope under VU light.
Viscosity measurements.
Viscosity studies were done in a Cannon-Manning semi micro viscometer (size 50) immersed in a thermostat bath maintained at 27 ± 1° C. The concentration of CT-DNA was kept constant at 1 mmol and viscosity of the CT-DNA was measured by increasing the concentration of the . The flow times were measured after thermal equilibration of at least 30 min. Each sample was measured three times and the averaged time was used in calculations. Invasion assay. 2.5 X 10 4 MDA-MB231 highly metastatic breast cancer cells seeded onto each well of 24 well matrigel plate chamber. Below the matrigel chamber 750 µL of fetal bovine serum was placed as chemo-attractant for the MDA-MB231 cells to invade. Cells were treated with complex 1 and 2 for 4 h and then either exposed to dark or visible light conditions for 4 h. The cells were then allowed to invade the matrigel over-night at 37 °C in a humidified 95 % incubator. Next day, the noninvading cells were removed using moistened cotton swabs. Cells were fixed with 100 % chilled methanol for 15 min and then washed with phosphate buffered saline (1 X PBS) three times. 0.4 % crystal violet was prepared and then 500 µL was applied into the chamber containing matrigel and invaded cells. After 15 min of crystal violet staining, three PBS washes given and then air dried. The chamber was then placed under an inverted microscope to count the number of invaded cells.
Western blotting.
Cells were lysed in TNN buffer (50 mM Tris, pH 7.5, 5mM EDTA, 0.5 % NP40 150 mM NaCl and 1 mM DTT), supplemented with protease inhibitor cocktail. The concentration of total protein in the cell lysate was determined by Bradford reagent (Thermo scientific). 40 μg of each protein was loaded onto 10 % SDS-PAGE, and protein was transferred onto PVDF membrane (Millipore) using western blot technique. After the completion of protein transfer, the membrane was blocked for 2 h at room temperature in 5 % BSA (MP Biomedicals). The blot was then washed with 1 X TBST (Tris buffer saline, 0.1 % Tween 20) 3 times, each for 5 min. The blot was probed with primary antibodies against caspase-3 and β-actin (Santa Cruz) for 2 h in 1:1000 dilutions for caspase-3 and 1:4000 dilutions for β-actin. After washing the blot in 1 X TBST, secondary antibody which is conjugated with Horseradish peroxidase was then added in 1:4000 dilutions in 1 X TBST buffer. The blot was then developed using autoradiography in X-ray film.
Conclusions
Two Ru(II)-polypyridyl complexes conjugated with amino acids tyrosine (1) and tryptophan (2) were investigated for their potential application as photodynamic therapeutic (PDT) agents. Complexes 1 and 2 showed preferential binding CT-DNA with moderately strong binding affinity K a = 1-5 X 10 5 mol -1 . Isothermal titration calorimetry (ITC) studies indicate that the reactions of both 1 and 2 with CT-DNA were entropically driven. Viscosity studies proved that 1 and 2 binds CT-DNA through groove binding. Most importantly, complexes 1 and 2 exhibits photo-induced cytotoxic activity in the presence of visible light at lesser exposure time and found to be low-toxic in the dark conditions (the key feature required by the PDT agents). These two-visible light excitable Ru(II) complexes showed apoptosis activity, prevents the cells from invasion and capable of producing significant levels of 1 O 2 that is which damages the DNA upon photo-irradiation.
